sapanisertib
Showing 1 - 14 of 14
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Laboratory
Completed
- Advanced Malignant Solid Neoplasm
- +3 more
- Laboratory Biomarker Analysis
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 21, 2022
Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Trial in Houston
Active, not recruiting
- Recurrent Lung Non-Small Cell Carcinoma
- +4 more
- Alisertib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
Leptomeningeal Tumor, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain Trial in United States
Recruiting
- Leptomeningeal Neoplasm
- +6 more
- Sapanisertib
- Telaglenastat Hydrochloride
-
Duarte, California
- +6 more
Dec 29, 2022
NSCLC, Squamous Non-small-cell Lung Cancer, Squamous Non-Small Cell Tumor of Lung Trial in United States (sapanisertib)
Recruiting
- Non-Small Cell Lung Cancer
- +3 more
- sapanisertib
-
Davis, California
- +13 more
Nov 7, 2022
Recurrent Lung Squamous Cell Carcinoma, Stage IV Lung Squamous Cell Carcinoma AJCC v7 Trial in United States (Laboratory
Completed
- Recurrent Lung Squamous Cell Carcinoma
- Stage IV Lung Squamous Cell Carcinoma AJCC v7
- Laboratory Biomarker Analysis
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Mar 16, 2022
Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial (Nivolumab,
Withdrawn
- Lung Non-Small Cell Carcinoma
- +12 more
- Nivolumab
- Sapanisertib
- (no location specified)
May 24, 2022
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Non-Small Cell Cancer AJCC v7
Active, not recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +5 more
- Laboratory Biomarker Analysis
- +3 more
-
New Haven, Connecticut
- +4 more
Jan 27, 2023
Endometrial Tumors Trial in Worldwide (Paclitaxel, Sapanisertib, MLN1117)
Breast Cancer Trial in Belgium, France, United States (Sapanisertib, Fulvestrant, Exemestane)
Completed
- Breast Cancer
- Sapanisertib
- +2 more
-
Los Angeles, California
- +39 more
Dec 16, 2020
Breast Tumors Trial in Spain, United States (Fulvestrant, Sapanisertib)
Non-hematologic Malignancy Trial in United States (Sapanisertib, Paclitaxel)
Completed
- Non-hematologic Malignancy
- Sapanisertib
- Paclitaxel
-
Scottsdale, Arizona
- +4 more
Feb 14, 2020
High Grade Sarcoma, Metastatic Leiomyosarcoma, Metastatic Malignant Peripheral Nerve Sheath Tumor Trial in United States
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022